Linked e-resources
Details
Table of Contents
Genomic structure of the KLK locus
Single nucleotide polymorphisms in the human KLK locus and their implication in various diseases
Evolution of Kallikrein-related peptidases
Structural aspects of Kallikrein-related peptidases
Molecular recognition properties of Kallikrein-related peptidases on synthetic and endogenous substrates
Natural, engineered, and synthetic inhibitors of Kallikrein-related peptidases
Kallikrein-related peptidases as pharmaceutical targets
Expression of Kallikrein-related peptidases under (patho) physiological conditions
Kallikrein-related peptidases within the proteolytic web
Kallikrein-Kinin cascade: bioregulation by human tissue kallikrein 1 (HK1, KLK 1)
Role of KLK4 in dental enamel formation.
Kallikrein-related peptidases and semen
Kallikrein-related peptidases and inhibitors of the skin
Physiological and pathophysiological roles of Kallikrein-related peptidases in the central nervous system
Kallikrein-related peptidases (KLKS), proteinase-mediated signaling and proteinase-activated receptors (PARS)
Pathophysiology of Kallikrein-related peptidases in lung cancer
Clinical relevance of Kallikrein-related peptidases in gastric and colorectal cancer
Pathophysiology of Kallikrein-related peptidases in head and neck cancer
PSA (prostate-specific antigen) and other Kallikrein-related peptidases in prostate cancer
Cellular model systems to study the tumor biological role of Kallikrein-related peptidases in ovarian and prostate cancer
Clinical relevance of Kallikrein-related peptidases in breast cancer
Clinical relevance of Kallikrein-related peptidases in ovarian cancer
MicroRNAs : a new control mechanism for Kallikrein-related peptidases in kidney and other cancers
Genomic instability of the KLK-locus in cancer
Kallikrein-related peptidases as biomarkers in personalized cancer medicine.
Single nucleotide polymorphisms in the human KLK locus and their implication in various diseases
Evolution of Kallikrein-related peptidases
Structural aspects of Kallikrein-related peptidases
Molecular recognition properties of Kallikrein-related peptidases on synthetic and endogenous substrates
Natural, engineered, and synthetic inhibitors of Kallikrein-related peptidases
Kallikrein-related peptidases as pharmaceutical targets
Expression of Kallikrein-related peptidases under (patho) physiological conditions
Kallikrein-related peptidases within the proteolytic web
Kallikrein-Kinin cascade: bioregulation by human tissue kallikrein 1 (HK1, KLK 1)
Role of KLK4 in dental enamel formation.
Kallikrein-related peptidases and semen
Kallikrein-related peptidases and inhibitors of the skin
Physiological and pathophysiological roles of Kallikrein-related peptidases in the central nervous system
Kallikrein-related peptidases (KLKS), proteinase-mediated signaling and proteinase-activated receptors (PARS)
Pathophysiology of Kallikrein-related peptidases in lung cancer
Clinical relevance of Kallikrein-related peptidases in gastric and colorectal cancer
Pathophysiology of Kallikrein-related peptidases in head and neck cancer
PSA (prostate-specific antigen) and other Kallikrein-related peptidases in prostate cancer
Cellular model systems to study the tumor biological role of Kallikrein-related peptidases in ovarian and prostate cancer
Clinical relevance of Kallikrein-related peptidases in breast cancer
Clinical relevance of Kallikrein-related peptidases in ovarian cancer
MicroRNAs : a new control mechanism for Kallikrein-related peptidases in kidney and other cancers
Genomic instability of the KLK-locus in cancer
Kallikrein-related peptidases as biomarkers in personalized cancer medicine.